Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05141890 · ClinicalTrials.gov registry record · NA
Probiotics for Inflammation in Pediatric Chronic Pain
A NA study of Chronic Pain and Body Mass Index >=85th Percentile, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT05141890: Active NA study of Chronic Pain and Body Mass Index >=85th Percentile, sponsored by Medical College of Wisconsin.
NCT05141890 is a NA study of Chronic Pain and Body Mass Index >=85th Percentile that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 39 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05141890, a NA study of Chronic Pain and Body Mass Index >=85th Percentile, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
To examine benefits of a probiotic for youth with chronic pain and a Body Mass Index \>=85th percentile.
Primary Outcome
Change in circulating C-Reactive Protein after 8 weeks of probiotic supplement.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Lactobacillus Plantarum
Study Locations (1)
Wisconsin
- Children's Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2022-04-25 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the registry record for NCT05141890 still lists
NCT05141890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Lactobacillus Plantarum is the first listed.
NCT05141890 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05141890 about?
NCT05141890 is a clinical study titled "Probiotics for Inflammation in Pediatric Chronic Pain". To examine benefits of a probiotic for youth with chronic pain and a Body Mass Index \>=85th percentile.
What is the current status of trial NCT05141890?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2022-04-25. Estimated completion is 2026-06-01.
What conditions does trial NCT05141890 study?
This clinical trial studies the following conditions: Chronic Pain, Body Mass Index >=85th Percentile.
What interventions are being tested in trial NCT05141890?
The interventions under investigation include: Lactobacillus Plantarum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05141890?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05141890 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05141890's enrollment target sits among peer trials
39 222nd of 301 higher than 79 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI